Bushido Capital US SMID Cap Equity ETF Rating $31.44 0.00 (0.00%) As of 05/22/2026 03:59 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Bushido Capital US SMID Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RNIN Aggregate RatingHold 2.48Holdings in RNIN have an aggregate rating of Hold based on 312 analyst ratings issued in the past year covering 25 companies (37.6% of the portfolio).RNIN Aggregate Price Target$31.44High Prediction$31.44Average Prediction$31.44Low Prediction$31.44Holdings in RNIN have an aggregate price target of $31.44 and a range of $31.44 to $31.44 covering 25 companies (37.6% of the portfolio).RNIN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Bushido Capital US SMID Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 RNIN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.33%OSCROscar Health$22.67+0.1%3.4973 of 5 stars2.17$18.22 -19.6%121.68%SNXTD SYNNEX$237.300.0%4.2709 of 5 stars2.91$197.70 -16.7%11Gap Down1.68%TGTXTG Therapeutics$38.874.3474 of 5 stars2.57$52.50 35.1%71.67%MNKDMannKind$3.383.8687 of 5 stars2.60$8.84 161.6%101.56%VCVisteon$113.474.0298 of 5 stars2.64$124.42 9.6%14Positive NewsDividend Announcement1.56%NUTXNutex Health$118.912.697 of 5 stars2.50$205.00 72.4%21.56%PGNYProgyny$24.884.0138 of 5 stars2.92$29.55 18.8%131.55%CPRXCatalyst Pharmaceuticals$31.263.8178 of 5 stars2.63$32.17 2.9%8Negative News1.54%PTONPeloton Interactive$5.714.0441 of 5 stars2.29$8.25 44.5%14High Trading Volume1.52%ONonsemi$116.203.7239 of 5 stars2.50$89.19 -23.2%30Trending NewsGap Down1.51%JAZZJazz Pharmaceuticals$239.832.549 of 5 stars2.84$241.53 0.7%19Analyst Forecast1.47%NTCTNetScout Systems$41.012.1668 of 5 stars2.67$35.50 -13.4%3Positive NewsGap Down1.45%CROXCrocs$110.442.1817 of 5 stars2.13$103.73 -6.1%15Positive News1.45%PVHPVH$88.900.0%3.222 of 5 stars2.35$88.93 0.0%17Gap Down1.44%BWABorgWarner$65.88+0.1%3.8273 of 5 stars2.50$67.64 2.7%14Positive News1.42%MTCHMatch Group$35.804.8391 of 5 stars2.40$41.07 14.7%151.41%ETSYEtsy$62.48+0.2%3.7497 of 5 stars2.34$70.75 13.2%32Analyst UpgradeGap Down1.38%HRBH&R Block$38.94+0.1%3.9178 of 5 stars2.50$41.00 5.3%4Gap Down1.38%INSWInternational Seaways$83.62+0.1%3.0044 of 5 stars2.71$83.50 -0.1%71.35%NTNXNutanix$47.123.9899 of 5 stars2.58$60.87 29.2%19Upcoming EarningsAnalyst ForecastGap Down1.35%HRMYHarmony Biosciences$30.154.4998 of 5 stars2.27$40.89 35.6%11Analyst ForecastAnalyst Revision1.35%CRMDCorMedix$7.983.1918 of 5 stars2.75$15.00 88.0%81.33%DBXDropbox$27.432.6679 of 5 stars1.83$27.00 -1.6%61.32%TENBTenable$25.453.4311 of 5 stars2.40$28.79 13.1%20Analyst Forecast1.31%NEUNewMarket$736.60-0.2%1.2238 of 5 stars2.001 This page (NASDAQ:RNIN) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bushido Capital US SMID Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Bushido Capital US SMID Cap Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
